Policy paper

Statement on arrangements for pricing branded medicines from 2014

The Association of the British Pharmaceutical Industry and the Department of Health have published a Joint DH/ABPI statement

• From: Department of Health and Social Care
• Published: 3 August 2012

This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Applies to England

Documents

Joint DH/ABPI statement on arrangements for pricing branded medicines from 2014

PDF, 45 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The negotiations, which are set to begin in September, will determine the arrangements for pricing branded medicines in the UK from 2014, including medicines that are already on the market in December 2013 and new medicines which are launched from January 1 2014.

Published 3 August 2012